secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2026-05-19T20:05:26+00:00
Accession:  0001213900-26-058997
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix announces 1-for-10 reverse stock split effective May 21, 2026 to meet Nasdaq bid price rule
--------------------------------------------------------------------------------

- Board fixed 1-for-10 reverse split ratio; effective 12:01 a.m. ET on May 21, 2026.
- Reverse split reduces outstanding shares from ~11.4M to ~1.14M; no change in authorized shares or par value.
- Split intended to regain compliance with Nasdaq $1.00 minimum bid price rule for continued listing.
- No fractional shares issued; holders of fractional shares will receive cash compensation based on closing price on May 20, 2026.
- Common stock continues trading on Nasdaq Capital Market under symbol ONCO with new CUSIP 68237Q 401.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026058997/0001213900-26-058997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026058997/ea0291543-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-058997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer